Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to 0.4%.

  • Bicycle Therapeutics' Return on Capital Employed fell 2000.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.3% for FY2024, which is 1400.0% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Return on Capital Employed stood at 0.4%, which was down 2000.0% from 0.37% recorded in Q2 2025.
  • Bicycle Therapeutics' Return on Capital Employed's 5-year high stood at 0.18% during Q1 2022, with a 5-year trough of 0.4% in Q3 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.3% (2021), whereas its average is 0.3%.
  • Per our database at Business Quant, Bicycle Therapeutics' Return on Capital Employed soared by 1700bps in 2021 and then plummeted by -2000bps in 2025.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Return on Capital Employed stood at 0.19% in 2021, then tumbled by -70bps to 0.32% in 2022, then dropped by -7bps to 0.35% in 2023, then surged by 33bps to 0.23% in 2024, then plummeted by -72bps to 0.4% in 2025.
  • Its last three reported values are 0.4% in Q3 2025, 0.37% for Q2 2025, and 0.29% during Q1 2025.